BioMCN to double capacity with €100 million investment
OCI N.V. (Euronext: OCI), BioMCN’s parent company, announced an estimated €100 million investment to refurbish the second methanol production line at BioMCN, located at Chemical Park Delfzijl.
The production facility is currently mothballed, but prospects for methanol markets are attractive and the restart will create approximately 30 new permanent jobs at the site, in addition to several hundred indirect jobs during the refurbishment.
The production line can produce 438,000 tons of methanol per year and will almost double BioMCN’s current production capacity. The plant is expected to start commissioning in the fourth quarter of 2018.
The BioMCN plant in Delfzijl doubles its capacity
Categories
Investments
Chemical substances
Countries
Latest news
INEOS launches €250m investment supported by the French Government to secure the future of French industry at Lavera
The project marks the first phase of a long-term regeneration plan to reduce emissions, boost reliability, efficiency and competitiveness, with support of the French State.
Hycamite’s technology to decarbonize shipping awarded AiP by industry leader DNV
Kokkola Industrial Park →Hycamite’s proprietary Thermo-Catalytic Decomposition (TCD) technology offers a new approach to producing clean hydrogen by breaking down methane, the primary component of liquefied natural gas (LN...
Clariant catalysts will power the Ecoplanta: Europe's first waste-to-methanol plant
Chemmed Cluster Tarragona →Repsol is building Europe’s first plant to produce renewable methanol from urban waste The facility will use Enerkem gasification technology to produce 240 KTA of methanol Clariant will supply cata...
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain